The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer

By Campos S.M.   Penson R.T.   Mays A.R.   Berkowitz R.S.   Fuller A.F.   Goodman A.   Matulonis U.A.   Muzikansky A.   Seiden M.V.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 206-212

Elsevier

Access to resources Recommend Favorite

Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer

By Garcia Agustin A.   Yessaian Anne   Pham Huyen   Facio Grace   Muderspach Laila   Roman Lynda  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 295-299

Informa Healthcare

Access to resources Recommend Favorite

Clinical Outcome of Tertiary Surgical Cytoreduction in Patients with Recurrent Epithelial Ovarian Cancer

By Fotopoulou Christina  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 49-57

Springer Publishing Company

Access to resources Recommend Favorite

Clinical disease course during the last year in ovarian cancer

By von Gruenigen V.E.   Frasure H.E.   Reidy A.M.   Gil K.M.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 619-624

Elsevier

Access to resources Recommend Favorite

Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer

By Morgan M.A.   Stadtmauer E.A.   Luger S.M.   Porter D.L.   Mangan P.A.   O'neil P.   Kamelle S.   Benjamin I.   Mick R.   King S.A.   Rubin S.C.  

Gynecologic Oncology, Vol. 67, Iss. 3, 1997-12 ,pp. : 272-276

Elsevier

Access to resources Recommend Favorite